CD40 ligand
| GO Term | Evidence Code | PMID |
|---|---|---|
| inflammatory response |
|
|
| inflammatory response |
|
|
| immune response |
|
|
| cell surface receptor signaling pathway |
|
|
| platelet activation |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| obsolete extracellular space |
|
|
| plasma membrane |
|
|
| plasma membrane |
|
|
| cell surface |
|
|
| cell surface |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| cytokine activity |
|
|
| cytokine activity |
|
|
| tumor necrosis factor receptor binding |
|
|
| CD40 receptor binding |
|
|
| CD40 receptor binding |
|
| Gene Ontology |
|---|
| CD40 receptor binding |
| cytokine activity |
| immune response |
| tumor necrosis factor receptor binding |
| InterPro |
|---|
| CD40 ligand |
| Tumour necrosis factor domain |
| Tumour necrosis factor, conserved site |
| Tumour necrosis factor-like domain superfamily |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026